About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
https://www.weizmann-usa.org/news-media/feature-stories/evolutionary-safety-first/
Feb 21, 2024... At the height of the coronavirus pandemic, pharmaceutical company Merck received emergency, fast-track approval from the USDA for a new drug called molnupiravir, which tricks the SARS-CoV-2 virus into mutating so quickly that it kills itself off. One social media user’s logical response to the news got the attention of Prof. Yitzhak Pilpel in Weizmann’s Molecular Genetics Department: Could humans encounter more dangerous strains of coronavirus and end up paying a heavy price for this innovation?